Table 1 Subject Demographics in the Antibody Persistence Phase and the MenACWY-TT Booster Phase
Demographic | Antibody Persistence Phase | MenACWY-TT Booster Phase | ||
|---|---|---|---|---|
Primary MenACWY-TT | Primary MenACWY-PS | Primary MenACWY-TT | Primary MenACWY-PS | |
Total enrolled cohort, n | 235 | 76 | 164 | 56 |
Sex, n (%) | ||||
Male | 127 (54.0) | 36 (47.4) | 93 (56.7) | 29 (51.8) |
Female | 108 (46.0) | 40 (52.6) | 71 (43.3) | 27 (48.2) |
Age at enrollment, y | ||||
Mean ± SD | 25.3 ± 8.2 | 25.2 ± 8.4 | 26.8 ± 7.9 | 27.4 ± 8.7 |
Median (range) | 22.0 (18–60) | 22.0 (18–55) | 24.0 (21–63) | 24.5 (21–56) |
Race, n (%) | ||||
Asian/Southeast Asian | 235 (100) | 76 (100) | 164 (100) | 56 (100) |